Hongri Pharmaceutical is a well-known pharmaceutical company in China, mainly engaged in the development, production and sales of pharmaceutical products.
The company was founded in 1995. After years of development, it now has multiple production bases and hundreds of products, covering multiple treatment fields. During the epidemic, Hongri Pharmaceutical actively responded to the national call, deployed production lines, increased the production of vaccines, masks and other epidemic prevention materials, and contributed to the fight against the epidemic. At present, Hongri Pharmaceutical continues to promote corporate transformation and upgrading, strengthen innovation capabilities and brand building, actively expand overseas markets, and continue to develop steadily. Although the company's performance has fluctuated due to factors such as the epidemic and industry policy adjustments, generally speaking, investors are optimistic about its future development prospects.